Drugs / 68Ga-THP-PSMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04158817 | Nov 2019 → Mar 2023 | prostate cancer | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-THP-PSMA | “All participants in the study will be injected with 68Ga-THP-PSMA at a dose of 2.11 MBq/kg in a single dose injection.” NCT04158817 ↗ |
| Modality | Diagnostic / imaging agent | “detection rate of 68Ga-THP-PSMA PET/CT” NCT04158817 ↗ |